The Sentinel System is increasingly recognized as a vital resource able to support the needs of diverse stakeholders, including other public health agencies, health systems, regulated industry, the clinical research enterprise, and patients.
However, individuals whose data are used to support Sentinel, as well as the general public, are largely unaware of Sentinel’s existence, health and safety mission, and commitment to protect patient privacy.
Therefore, when FDA officially launched the Sentinel System early in 2016, it was both timely and critical to identify opportunities to raise awareness and understanding of the Sentinel System, and to build trusted support for Sentinel among patients, consumers, and the general public, to complement existing communication efforts undertaken by the Agency and the Sentinel Operations Center.
Consequently, FDA formed a multi-stakeholder workgroup to raise awareness among four critical engagement partners:
- The Public
- Health Advocacy Groups
- Health Plan Members
The Sentinel Stakeholder Engagement Workgroup
January 30, 2018
The mission of the Sentinel Stakeholder Engagement Workgroup was to develop messages to inform engagement partners about the Sentinel System, letting them know what a valuable tool it is and how it works, and to remind them of the FDA’s commitment to protect patient privacy. The workgroup was led by a Patient Representative to the Sentinel Planning Board. Workgroup members included representatives of the patient community, health advocacy groups, providers, health plan members, the Sentinel System staff, and the FDA.
The workgroup developed the Infographic below as well as targeted versions of the Sentinel System Story for each of the four engagement partners. The stories intended for the Public and Providers are shown here on the Sentinel website. The stories for Health Advocacy Groups and Health Plan Members were developed as templates for further dissemination by those engagement partners. The information provided in the Infographic and stories is intended to inform the public about the Sentinel System, but do not constitute official FDA communications.
The FDA and Sentinel Operations Center welcome comments on the Infographic and stories at firstname.lastname@example.org.
March 1, 2019
This project reconvened the Sentinel Stakeholder Engagement Workgroup to develop and disseminate enhanced messaging concerning Sentinel’s expanded role in supporting FDA’s regulatory mission and exploring the potential of the Sentinel System to support studies of the efficacy of medical products. The Workgroup clarified Sentinel’s value to important constituencies, including patients, providers, data partner members, and the public.